Thoughts on DESTINY-Breast04 for HER2-low metastatic breast cancer.
Joseph GLIGOROV
Oncologist, Paris, France
Oncologist, Paris, France
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
15.15 I 15.30
Maan HACHIMI
Marc SPIELMANN
Expert Opinions Dubai 2022
BCU Honorary President
Copyright © 2026 - BCU